A study of relapse after MDT in a district in West Bengal, India

Indian Journal of Leprosy

Volumn 75, Issue 1, 2003, Pages 1-8

  Haldar, Anima ^a   Mahapatra, B S ^b   Mundle, M ^c   Haldar, S ^d   Saha, A K ^a  

^a MEDICAL COLLEGE AND HOSPITAL   (India)

^b BANKURA SAMMILANI MEDICAL COLLEGE   (India)

^c IPGMER   (India)

^d Government of West Bengal   (India)

Author keywords

[No Author keywords available]

Indexed keywords

LEPROSTATIC AGENT; STEROID;

ADOLESCENT; ADULT; AGE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GENDER; GOVERNMENT; HUMAN; INDIA; INFANT; LEPROSY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MULTIBACILLARY LEPROSY; NEWBORN; PAUCIBACILLARY LEPROSY; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RELAPSE; RELIABILITY; RISK FACTOR;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INDIA; INFANT; INFANT, NEWBORN; LEPROSTATIC AGENTS; LEPROSY; MALE; MIDDLE AGED; MYCOBACTERIUM LEPRAE; NATIONAL HEALTH PROGRAMS; ORGANIZATIONS; POPULATION SURVEILLANCE; RECURRENCE; RISK FACTORS;

EID: 0037908898     PISSN: 02549395     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Constant-Desportes M, Guelpa-Lauras CC, Catalina JC, Leoture A, Grosset JH, Sansarricq H (1991). A case of relapse with drug susceptible M. leprae after multidrug therapy. Int J Lepr 59: 242-7
2. Ganapati R, Pal R, Gandewar KL, Thressia XJ (1989). Fow how long should a multibacillary leprosy patient be treated? Indian J Lepr 61: 467-71
3. Girdhar BK, Girdhar A, Kumar A (2000). Relapses in multibacillary leprosy patients: Effect of length of therapy. Lepr Rev 71: 144-53
4. Government of India (2000). NLEP Status Report. Country Report. Government of India
5. Government of West Bengal (2000). NLEP Status Report, West Bengal.
6. Government of West Bengal. Health on the March, 2000-2001. p.7
7. Katoch K, Natarajan M, Bagga A et al (1991). Clinical and bacteriological progress of highly bacillated BL-LL patients discontinuing treatment after different periods of MDT. Int J Lepr 59: 248-54
8. Mahapatra BS (1990). Study of the magnitude of the problem of relapse from multidrug therapy among leprosy cases during surveillance. Dissertation for MD (PSM), pp 36-9
9. Marchoux Chemotherapy Study Group (1992). Relapses in multibacillary leprosy patients after stopping treatment with rifampicin containing combined regimens. Int J Lepr 60: 525-33
10. Noordeen SK (1991). A look at world leprosy. Lepr Rev 62: 72-86
11. Pandian G et al (1984). A study of relapse in non-lepromatous and indeterminate group of leprosy in the ELEP Leprosy Control Project, Dharmapuri. XII International Leprosy Congress Proceedings, New Delhi, 20-25 February 1984
12. Wallace RB (1998) (Ed.) Maxcy-Rosenau-Last. Public Health and Preventive Medicine (14th edn.). Prentice Hall International. p.221
13. World Health Organization (1998). WHO Expert Committee on Leprosy. Seventh report. WHO Technical Report Series, No. 874. Geneva, World Health Organization
14. Van Brakel W, Kist P, Noble S, O'Toole L (1989). Relapses after multidrug therapy for leprosy: A preliminary report of 22 cases in West Nepal. Lepr Rev 60: 45-50